These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
185 related items for PubMed ID: 11576570
1. A prospective, controlled study of the effects of hormonal contraception on bone mineral density. Berenson AB, Radecki CM, Grady JJ, Rickert VI, Thomas A. Obstet Gynecol; 2001 Oct; 98(4):576-82. PubMed ID: 11576570 [Abstract] [Full Text] [Related]
2. Effects of hormonal contraception on bone mineral density after 24 months of use. Berenson AB, Breitkopf CR, Grady JJ, Rickert VI, Thomas A. Obstet Gynecol; 2004 May; 103(5 Pt 1):899-906. PubMed ID: 15121563 [Abstract] [Full Text] [Related]
3. Bone density in women receiving depot medroxyprogesterone acetate for contraception. Cundy T, Evans M, Roberts H, Wattie D, Ames R, Reid IR. BMJ; 1991 Jul 06; 303(6793):13-6. PubMed ID: 1830502 [Abstract] [Full Text] [Related]
7. Effect of depot medroxyprogesterone acetate on bone mineral density in adolescent women. Zhang MH, Zhang W, Zhang AD, Yang Y, Gai L. Chin Med J (Engl); 2013 Nov 06; 126(21):4043-7. PubMed ID: 24229671 [Abstract] [Full Text] [Related]
8. Depot medroxyprogesterone acetate, oral contraceptives and bone mineral density in a cohort of adolescent girls. Cromer BA, Stager M, Bonny A, Lazebnik R, Rome E, Ziegler J, Debanne SM. J Adolesc Health; 2004 Dec 06; 35(6):434-41. PubMed ID: 15581522 [Abstract] [Full Text] [Related]
9. Effect of two kinds of different combined oral contraceptives use on bone mineral density in adolescent women. Gai L, Jia Y, Zhang M, Gai P, Wang S, Shi H, Yu X, Liu Y. Contraception; 2012 Oct 06; 86(4):332-6. PubMed ID: 22364818 [Abstract] [Full Text] [Related]
10. Long-term depot-medroxyprogesterone acetate and bone mineral density. Tang OS, Tang G, Yip P, Li B, Fan S. Contraception; 1999 Jan 06; 59(1):25-9. PubMed ID: 10342083 [Abstract] [Full Text] [Related]
11. Bone mineral density changes over two years in first-time users of depot medroxyprogesterone acetate. Clark MK, Sowers MR, Nichols S, Levy B. Fertil Steril; 2004 Dec 06; 82(6):1580-6. PubMed ID: 15589863 [Abstract] [Full Text] [Related]
12. Bone mineral density in women aged 40-49 years using depot-medroxyprogesterone acetate, norethisterone enanthate or combined oral contraceptives for contraception. Beksinska ME, Smit JA, Kleinschmidt I, Farley TM, Mbatha F. Contraception; 2005 Mar 06; 71(3):170-5. PubMed ID: 15722065 [Abstract] [Full Text] [Related]
13. Bone density among long-term users of medroxyprogesterone acetate as a contraceptive. Paiva LC, Pinto-Neto AM, Faundes A. Contraception; 1998 Dec 06; 58(6):351-5. PubMed ID: 10095971 [Abstract] [Full Text] [Related]
15. Bone mineral density in adolescents using norethisterone enanthate, depot-medroxyprogesterone acetate or combined oral contraceptives for contraception. Beksinska ME, Kleinschmidt I, Smit JA, Farley TM. Contraception; 2007 Jun 06; 75(6):438-43. PubMed ID: 17519149 [Abstract] [Full Text] [Related]
18. Bone mineral density in adolescent females using depot medroxyprogesterone acetate. Lara-Torre E, Edwards CP, Perlman S, Hertweck SP. J Pediatr Adolesc Gynecol; 2004 Feb 06; 17(1):17-21. PubMed ID: 15010034 [Abstract] [Full Text] [Related]